Grow with us
HAY pharma - cannabinoid pharmaceuticals
“made in Europe”
About HAY pharma
HAY pharma is a fast-growing European manufacturer and wholesaler of cannabinoid-containing medicines. In Germany, the company operates from Dortmund and Munich. HAY’s business model integrates the highest quality with continuous availability of all phytopharmaceutical products such as cannabis flowers and cannabis extracts. HAY’s production is fully GMP certified by German authorities and guarantees unique quality with a highly competitive cost structure. HAY’s GDP licensed distribution with focus on major European markets such as Germany offers attractive growth opportunities in the new market for cannabis containing
pharmaceuticals.
Standards
Highest pharmaceutical standards according to GMP and GDP certified by German authorities - HAY serves the most respected global standard for cannabinoid medicine.
Product diversity
APIs / active ingredients as well as many cannabis flowers with high cannabinoid concentration (THC, CBD), various standardized extracts with different effect combination, cannabis resin and innovative further dosage forms.
Scalability
Our unique production sites offer room for further growth, our very favorable production costs make us fit for the future. In an increasingly price-competitive market, our profitability is not threatened.
Would you like to invest in HAY pharma?
Investor Relations
Personal contact
Ricardo Pendon Victorio
E: ir@hay-pharma.de